Efficiency of once-weekly subcutaneous administration of recombinant human erythropoietin versus three times a week administration in hemodialysis patients. 1996

M Lago, and R Pérez-García, and M S García de Vinuesa, and F Anaya, and F Valderrábano

UI MeSH Term Description Entries
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D004921 Erythropoietin Glycoprotein hormone, secreted chiefly by the KIDNEY in the adult and the LIVER in the FETUS, that acts on erythroid stem cells of the BONE MARROW to stimulate proliferation and differentiation.
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

M Lago, and R Pérez-García, and M S García de Vinuesa, and F Anaya, and F Valderrábano
January 1992, American journal of nephrology,
M Lago, and R Pérez-García, and M S García de Vinuesa, and F Anaya, and F Valderrábano
November 1991, Clinical nephrology,
M Lago, and R Pérez-García, and M S García de Vinuesa, and F Anaya, and F Valderrábano
January 1993, Nephron,
M Lago, and R Pérez-García, and M S García de Vinuesa, and F Anaya, and F Valderrábano
January 1992, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis,
M Lago, and R Pérez-García, and M S García de Vinuesa, and F Anaya, and F Valderrábano
April 1994, JPMA. The Journal of the Pakistan Medical Association,
M Lago, and R Pérez-García, and M S García de Vinuesa, and F Anaya, and F Valderrábano
January 1994, American journal of nephrology,
M Lago, and R Pérez-García, and M S García de Vinuesa, and F Anaya, and F Valderrábano
January 1991, Contributions to nephrology,
M Lago, and R Pérez-García, and M S García de Vinuesa, and F Anaya, and F Valderrábano
July 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
M Lago, and R Pérez-García, and M S García de Vinuesa, and F Anaya, and F Valderrábano
January 1998, Biotherapy (Dordrecht, Netherlands),
M Lago, and R Pérez-García, and M S García de Vinuesa, and F Anaya, and F Valderrábano
December 2010, The New England journal of medicine,
Copied contents to your clipboard!